Latest Percheron Therapeutics (ASX:PER) News
Page 1
Page 1 of 3
Healthcare Wrap - Week 45 (2 Nov -> 6 Nov) 2026
7 Nov 2026
Percheron lodges prospectus for 280 million options as funding risks remain in focus
4 Nov 2026
FDA Clears Percheron's HMBD-002 Trial in Relapsed AML
2 Nov 2026
Healthcare Wrap - Week 43 (19 Oct -> 23 Oct) 2026
24 Oct 2026
Percheron funds Vanderbilt AML trial as cash runway reaches 8.6 quarters
20 Oct 2026
Market Wrap - Week 36 (31 Aug -> 4 Sept) 2026
5 Sept 2026
Healthcare Wrap - Week 36 (31 Aug -> 4 Sept) 2026
5 Sept 2026
$2.3 Million Placement Secures Funding for Percheron's AML Trial
1 Sept 2026
Healthcare Wrap - Week 35 (24 Aug -> 28 Aug) 2026
29 Aug 2026
Percheron Therapeutics Launches Vanderbilt-Led Trial for HMBD-002 in AML
28 Aug 2026
Healthcare Wrap - Week 34 (17 Aug -> 21 Aug) 2026
22 Aug 2026